LAG-3-IN-1
LAG-3-IN-1 (Compound 11) is a LAG-3 inhibitor with a KD of 0.41 μM. LAG-3-IN-1 disrupts the LAG-3/MHCII interaction, enhances IFN-γ secretion and promotes tumor cell killing in cocultures of PBMCs and cancer cells. LAG-3-IN-1 can be used for cancers like ovarian cancer, colon adenocarcinoma and melanoma research[1].
Product Specifications
UNSPSC
12352005
Target
LAG-3
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
O=C([C@@H]1[C@H](CN(C1)CC2=NC=CC=C2)C3=CC=CC=C3)NCC4=CC=C(C=C4)C5=CC=CC=C5
Molecular Formula
C30H29N3O
Molecular Weight
447.57
References & Citations
[1]Abdel-Rahman SA, et al. Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer Immunotherapy. J Med Chem. 2025 Aug 20.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472848-100 1x 100 µL
Fibronectin (Fn-3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC050391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881505-100 1x 100 µL
CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) (Ki-1/1505R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402059-500 1x 500 µL
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742147-100 1x 100 µL
Cytokeratin, Basic (Type II or HMW) (KRTH/2147R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680889-500 1x 500 µL
PLAP (Placental Alkaline Phosphatase) (PL8-F6), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details